Marvin J. Sklar

ORCID: 0000-0003-4109-8924
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Malaria Research and Control
  • Viral Infections and Vectors
  • vaccines and immunoinformatics approaches
  • Mosquito-borne diseases and control
  • Drug-Induced Adverse Reactions
  • Global Health and Epidemiology
  • Zoonotic diseases and public health
  • Virology and Viral Diseases
  • Leptospirosis research and findings
  • HIV/AIDS drug development and treatment
  • Viral gastroenteritis research and epidemiology
  • Monoclonal and Polyclonal Antibodies Research
  • Infection Control and Ventilation
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Child Nutrition and Water Access
  • Pneumocystis jirovecii pneumonia detection and treatment

Naval Medical Research Command
2015-2025

Cambodia-Oxford Medical Research Unit
2023

Walter Reed National Military Medical Center
2015

Naval Medical Center San Diego
2011

Background A three-antigen DNA-prime/chimpanzee adenovirus 63 (ChAd63) boost vaccine containing pre-erythrocytic Plasmodium falciparum (Pf) circumsporozoite protein (CSP), Pf apical membrane antigen-1 (AMA1) and malaria multiple epitopes (ME) fused to thrombospondin-related adhesion (ME-TRAP) elicited higher efficacy (VE) in an open label, randomized Phase 1 trial against controlled human infection (CHMI) than the two-antigen DNA/Human Adenovirus 5 (HuAd5) CSP AMA1. The objective of this...

10.1371/journal.pone.0318098 article EN public-domain PLoS ONE 2025-02-13

Dengue is a global health problem and the development of tetravalent dengue vaccine with durable protection high priority. A heterologous prime-boost strategy has advantage eliciting immune responses through different mechanisms therefore may be superior to homologous strategies for generating immunity.In this phase 1 first-in-human study, 80 volunteers were assigned 4 groups received virus (DENV-1-4) purified inactivated (TDENV-PIV) alum adjuvant live attenuated (TDENV-LAV) in orders dosing...

10.1093/infdis/jiaa603 article EN public-domain The Journal of Infectious Diseases 2020-09-19

Background A DNA-prime/human adenovirus serotype 5 (HuAd5) boost vaccine encoding Plasmodium falciparum (Pf) circumsporozoite protein (PfCSP) and Pf apical membrane antigen-1 (PfAMA1), elicited protection in 4/15 (27%) of subjects against controlled human malaria infection (CHMI) that was statistically associated with CD8+ T cell responses. Subjects high level pre-existing immunity to HuAd5 were not protected, suggesting an adverse effect on efficacy (VE). We replaced chimpanzee 63 (ChAd63),...

10.1371/journal.pone.0256980 article EN public-domain PLoS ONE 2021-09-08

Diarrheal diseases are a leading cause of mortality and morbidity, disproportionally affecting persons residing in low middle-income countries. Accessing high-resolution surveillance data to understand community-level etiology risk remains challenging, particularly remote resource limited populations. A multi-year prospective cohort study was conducted two rural peri-urban villages Cambodia from 2012 2018 describe the epidemiology acute diarrheal within population. Suspected episodes among...

10.1371/journal.pone.0283871 article EN public-domain PLoS ONE 2023-03-31

Adverse drug reactions (ADRs) to antibiotics complicate the management of any infection, particularly opportunistic infections in advanced HIV as some ADRs are potentiated by HIV. Trimethoprim-sulfamethoxazole (TMP-SMX) causes 40-80% infected individuals, compared 3-5% general population. The incidence and severity among individuals appear increase they progress from latent infection AIDS. We present a single case report 55-year-old African American male found have an otherwise asymptomatic...

10.1155/2015/691010 article EN cc-by Case Reports in Infectious Diseases 2015-01-01
Coming Soon ...